Brain State Technologies announced the release of its BST Optimization Suite 4.0 software platform on Friday September 21, 2012. The system is based on 10 years of research and development, and employs over 3,000,000 brainwave patterns. More than 200 global offices feed the world’s largest relational data warehouse of brainwave activity 24/7/365. This continuous data stream generates a dynamic software infrastructure that adapts itself to newly acquired information, updates its own algorithms, and ‘automagically’ pushes these updates, in real-time, to worldwide offices.Continue reading
Category Archives: AZBio News
Provista raises $2.5 M
Provista Diagnostics Announces the Closing of Additional $2.5 Million Series A Preferred Financing Continue reading
UA Professor Directs Manufacture of Experimental Stroke Drug
By Alexis Blue, University Communications | September 20, 2012
Researchers think the drug 3K3A-APC, currently undergoing clinical trials in Europe, may help reduce brain damage and improve motor skills after a stroke.Continue reading
Medtronic seeks pharma partners for Alzheimer’s treatments
According to a receint article in FierceMedicalDevices, Medtronic ($MDT) believes its pump technology could pair well with the next generation of Alzheimer’s treatments, and the company is on the hunt for pharmaceutical partners.Continue reading
Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer’s protein
Mayo Clinic scientists believe they’ve found an enzyme that could defeat Alzheimer’s disease by destroying the brain-clogging protein that is a hallmark of the condition as it advances.Continue reading
AZBio Announces Finalists for 2012 Bioscience Company of the Year
The 2012 Bioscience Company of the Year will be announced at the AZBio Awards on October 23, 2012 at the Phoenix Convention Center.Continue reading
UACC Study looks at Broccoli and Tamoxifen – Participants Needed
A compound found in broccoli might be able to enhance the health-promoting effects of the breast cancer drug, Tamoxifen.Continue reading
HealthTell Opens in Innovations Incubator
Chandler, AZ—HealthTell Inc., a new biotechnology start-up company, is expanding its operations to the Innovations Incubator in Chandler. HealthTell has developed a system for providing “immunosignatures” for early screening and diagnosis of multiple diseases such as cancer and Alzheimer’s.Continue reading
UA College of Medicine Researcher Gets $1.9 Million Federal Grant
Faculty Member Earns Prestigious Award for Schizophrenia ResearchContinue reading
NEA’s David Mott on what VC firm’s $2.6B fund means for biotech (biotechVC)
New Enterprise Associates packs financial firepower like few other venture capital outfits today, particularly those investing in biotech. Fresh off closing a diversified venture fund of $2.6 billion revealed in July, NEA is expected to spend roughly a third of its capital from the fund on healthcare investments primarily in the biopharma industry, General Partner David Mott (who sold MedImmune to AstraZeneca ($AZN) for $15.6 billion in 2007), told FierceBiotech.Continue reading